表紙
市場調査レポート - 239720

体外診断 (IVD) の世界市場 〜2020年:製品 (器具、試薬、ソフトウェア、サービス) ・技術 (免疫測定、臨床化学、分子診断、血液学) ・用途別

In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

発行 MarketsandMarkets
出版日 ページ情報 英文 272 Pages
電子版即納可
価格
Back to Top
体外診断 (IVD) の世界市場 〜2020年:製品 (器具、試薬、ソフトウェア、サービス) ・技術 (免疫測定、臨床化学、分子診断、血液学) ・用途別 In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020
出版日: 2015年07月22日 ページ情報: 英文 272 Pages
概要

体外診断 (IVD) 検査は、現代の医療活動においては不可欠なツールです。IVD検査はいくつかの疾患を診断するために実施されます。バイオテクノロジーの発展に伴い、多様な疾患の診断のために実施される検査の種類において大幅な変化が生じており、これが疾患を適切かつ効果的に診断・治療する上で、世界中の医師を手助けしています。世界のIVD市場は、2020年には751億米ドルの規模に達する見込みとなっており、2015年から2020年にかけてのCAGR (複合年間成長率) は5.8%になるものと予測されています。

当レポートでは、体外診断 (IVD) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、製品別 (器具、試薬、ソフトウェア、サービス) ・技術別 (免疫測定、臨床化学、分子診断、血液学) ・用途別 (糖尿病、癌、心臓、自己免疫疾患) ・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

  • 調査の目的
  • 市場の定義
  • 市場の範囲
    • 網羅した市場
    • 調査の対象とした年
  • 通貨
  • 制約
  • ステークホルダー

第2章 調査手法

  • 調査データ
    • 二次データ
    • 一次データ
  • 市場規模推定
  • 市場内訳とデータの三角測量
  • 市場シェア推定
  • 調査の前提条件

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

  • IVD市場の成長可能性
  • アジア太平洋IVD市場
  • IVD市場:地域概観
  • 地域ミックス:IVD市場、技術別
  • IVD市場:新興VS先進市場

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 体外診断 (IVD) 市場、製品別
    • 体外診断 (IVD) 市場、技術別
    • 体外診断 (IVD) 市場、用途別
    • 体外診断 (IVD) 市場、エンドユーザー別
  • 市場動態
    • 市場発展促進要因
      • 世界的な慢性生活習慣病の発生率の上昇
      • 高齢者人口の急増
      • ポイントオブケア (POC) 検査の導入拡大
      • オーダーメイド医療の認知度の拡大
    • 市場発展阻害要因
      • 不十分な補償
      • 米国政府による物品税の導入
    • 市場機会
      • ゲノミクスおよびプロテオミクスの発展による新種の条件特有マーカー
      • 投資が増加している新興経済
    • 課題
      • 厳しい規制の枠組み

第6章 産業の洞察

  • イントロダクション
  • IVD市場の再編につながる主要企業により買収
  • ポーターのファイブフォース分析
  • 規制概要
    • 北米
      • 米国
      • カナダ
    • 欧州
    • アジア太平洋
      • 日本
      • 中国
      • インド
      • オーストラリア

第7章 世界のIVD市場、製品・サービス別

  • イントロダクション
  • 試薬とキット
  • 器具
  • データ管理ソフトウェア
  • 諸サービス

第8章 世界のIVD市場、技術別

  • イントロダクション
  • 臨床化学
  • 免疫化学/免疫測定法
  • 血液学
  • 凝析・止血
  • 微生物学
  • 分子診断学 (MDX)
  • その他のIVD技術

第9章 IVD市場、用途別

  • イントロダクション
  • 糖尿病
  • 感染症
  • 腫瘍/癌
  • 心臓
  • 腎臓
  • 自己免疫疾患
  • 薬物検査
  • HIV/AIDS
  • その他の用途

第10章 世界のIVD市場、エンドユーザー別

  • イントロダクション
  • 研究所
  • 病院
  • 学術機関
  • ポイントオブケア (POC) 検査
  • 患者の自己検査
  • その他

第11章 地域別分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州 (ROE)
  • アジア太平洋 (APAC)
    • 日本
    • 中国
    • インド
    • その他アジア太平洋 (ROAPAC)
  • その他地域 (ROW)
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ (RoLA)
    • 中東・アフリカ

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
  • 新製品発表
  • 合意、パートナーシップ、協力
  • 合併・買収
  • 事業拡張

第13章 企業プロファイル (業績、製品・サービス、主な戦略、最近の動き)

  • ABBOTT LABORATORIES, INC.
  • DANAHER CORPORATION
  • JOHNSON AND JOHNSON
  • ROCHE DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX
  • BIO-RAD LABORATORIES, INC.
  • ORTHO CLINICAL DIAGNOSTICS, INC.
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.

第14章 付録

  • 業界専門家の視点
  • 議論のガイド
  • その他の動向、2012-2015年
  • RTの紹介:リアルタイム (RT) 市場情報
  • 可能なカスタマイゼーション
  • 関連レポート

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

In vitro diagnostics (IVD) testing is an indispensable tool in the modern medical practice. IVD tests are conducted to diagnose a number of diseases. With the evolution of biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases; this helped physicians across the globe to diagnose and treat diseases promptly and effectively. The increasing usage of self-testing kits is the most important trend witnessed recently in the IVD industry is that of

The global IVD market is expected to reach USD 75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of chronic lifestyle diseases in emerging economies, growing aging population, and rising adoption of point-of-care testing and personalized medicine.

In this report, the market is segmented by product, technology, application, end user, and region. The IVD market, by product, is segmented into reagents and kits, instruments, services, and data management system/software. In 2014, the reagents and kits segment accounted for the largest share of approximately 79.3% of the IVD product market, and is expected to grow at a CAGR of 6.4% during the forecast period. Growth in this segment is mainly attributed to the increasing demand for diagnostic tests and launch of new reliable, specific, and faster detection reagents.

On the basis of applications, the IVD market is segmented into diabetes, infectious diseases, oncology, cardiology, HIV/AIDS, autoimmune diseases, drug testing, nephrology, and other applications. The oncology segment is expected to grow at the highest CAGR of 9.6% during the forecast period, owing to the increasing number of cancer patients across the world.

In 2014, North America commanded the largest share of the global IVD market, followed by Europe, Asia-Pacific, and the RoW. North America accounted for the largest share of 42.5% of global IVD market in 2014. The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. On the other hand, Asia-Pacific is the fastest-growing region in the global IVD market, mainly driven by the increasing demand for IVD tests from large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investment by leading players and respective government agencies in the region.

The major players in the IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Ortho-Clinical Diagnostics (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMerieux (France).

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by top players in the IVD market. The report analyzes the IVD market by product, technology, end user, and application across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the IVD market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the IVD market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the IVD market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
      • 2.1.2.3. Breakdown of primary interviews
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GROWTH POTENTIAL OF THE IVD MARKET
  • 4.2. ASIA-PACIFIC: IVD MARKET
  • 4.3. IVD MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. GEOGRAPHIC MIX: IVD MARKET, BY TECHNOLOGY
  • 4.5. IVD MARKET: EMERGING VS. DEVELOPED MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT
    • 5.2.2. IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
    • 5.2.3. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
    • 5.2.4. IN VITRO DIAGNOSTICS MARKET, BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Rising incidence of chronic lifestyle diseases across the globe
      • 5.3.1.2. Rapid growth in the geriatric population
      • 5.3.1.3. Increasing adoption of point-of-care (POC) testing
      • 5.3.1.4. Growing awareness of personalized medicine
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Inadequate reimbursement
      • 5.3.2.2. Implementation of excise duty by the U.S. government
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. New range of condition-specific markers and tests with advances in genomics and proteomics
      • 5.3.3.2. Emerging economies with increasing investments
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Stringent regulatory framework

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. ACQUISITIONS FROM LEADING PLAYERS RESULTING IN CONSOLIDATION OF THE IVD MARKET
  • 6.3. PORTER'S FIVE FORCE ANALYSIS
    • 6.3.1. THREAT OF NEW ENTRANTS
    • 6.3.2. THREAT OF SUBSTITUTES
    • 6.3.3. BARGAINING POWER OF SUPPLIERS
    • 6.3.4. BARGAINING POWER OF BUYERS
    • 6.3.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.4. REGULATORY OVERVIEW
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
    • 6.4.2. EUROPE
    • 6.4.3. ASIA-PACIFIC
      • 6.4.3.1. Japan
      • 6.4.3.2. China
      • 6.4.3.3. India
      • 6.4.3.4. Australia

7. GLOBAL IVD MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & KITS
  • 7.3. INSTRUMENTS
  • 7.4. DATA MANAGEMENT SOFTWARE
  • 7.5. SERVICES

8. GLOBAL IVD MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. CLINICAL CHEMISTRY
    • 8.2.1. BASIC METABOLIC PANELS
    • 8.2.2. ELECTROLYTE PANELS
    • 8.2.3. LIVER PANELS
    • 8.2.4. LIPID PROFILES
    • 8.2.5. RENAL PROFILES
    • 8.2.6. THYROID FUNCTION PANELS
    • 8.2.7. SPECIALTY CHEMICAL TESTS
  • 8.3. IMMUNOCHEMISTRY/IMMUNOASSAYS
    • 8.3.1. ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
      • 8.3.1.1. Chemiluminescence Immunoassays (CLIAs)
      • 8.3.1.2. Fluorescence Immunoassays (FIA)
      • 8.3.1.3. Colorimetric Immunoassays (CI)
    • 8.3.2. RADIOIMMUNOASSAYS (RIA)
    • 8.3.3. RAPID TESTS
    • 8.3.4. WESTERN BLOT
    • 8.3.5. ENZYME LINKED IMMUNOSPOT ASSAY (ELISPOT)
  • 8.4. HEMATOLOGY
  • 8.5. COAGULATION AND HEMOSTASIS
  • 8.6. MICROBIOLOGY
  • 8.7. MOLECULAR DIAGNOSTICS (MDX)
    • 8.7.1. POLYMERASE CHAIN REACTION (PCR)
    • 8.7.2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
    • 8.7.3. MICROARRAYS
    • 8.7.4. HYBRIDIZATION
    • 8.7.5. DNA SEQUENCING & NEXT-GENERATION SEQUENCING
    • 8.7.6. OTHER MDX TECHNOLOGIES
  • 8.8. OTHER IVD TECHNOLOGIES

9. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIABETES
  • 9.3. INFECTIOUS DISEASES
  • 9.4. ONCOLOGY/CANCER
  • 9.5. CARDIOLOGY
  • 9.6. NEPHROLOGY
  • 9.7. AUTOIMMUNE DISEASES
  • 9.8. DRUG TESTING
  • 9.9. HIV/AIDS
  • 9.10. OTHER APPLICATIONS

10. GLOBAL IVD MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. LABORATORIES
  • 10.3. HOSPITALS
  • 10.4. ACADEMIC INSTITUTES
  • 10.5. POINT-OF-CARE TESTING
  • 10.6. PATIENT SELF-TESTING
  • 10.7. OTHERS

11. GEOGRAPHIC ANALYSIS

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. RUSSIA
    • 11.3.7. REST OF EUROPE (ROE)
  • 11.4. ASIA-PACIFIC (APAC)
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. LATIN AMERICA
      • 11.5.1.1. Brazil
      • 11.5.1.2. Mexico
      • 11.5.1.3. Rest of Latin America (RoLA)
    • 11.5.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
  • 12.4. NEW PRODUCT LAUNCHES
  • 12.5. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • 12.6. MERGERS AND ACQUISITIONS
  • 12.7. EXPANSIONS

13. COMPANY PROFILES

  • 13.1. ABBOTT LABORATORIES, INC.
  • 13.2. DANAHER CORPORATION
  • 13.3. JOHNSON AND JOHNSON
  • 13.4. ROCHE DIAGNOSTICS
  • 13.5. SIEMENS HEALTHCARE
  • 13.6. BECTON, DICKINSON AND COMPANY
  • 13.7. BIOMERIEUX
  • 13.8. BIO-RAD LABORATORIES, INC.
  • 13.9. ORTHO CLINICAL DIAGNOSTICS, INC.
  • 13.10. SYSMEX CORPORATION
  • 13.11. THERMO FISHER SCIENTIFIC, INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS, 2012-2015
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASED INCIDENCE OF CHRONIC LIFESTYLE DISEASES AND RAPID GROWTH IN GERIATRIC POPULATION WILL DRIVE THE MARKET GROWTH
  • TABLE 2: LACK OF REIMBURSEMENT AND IMPLEMENTATION OF EXCISE DUTY TO RESTRAIN THE MARKET GROWTH
  • TABLE 3: EMERGING ECONOMIES WITH INCREASING INVESTMENTS OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET GROWTH
  • TABLE 4: STRINGENT REGULATIONS CONTINUE TO BE A KEY CHALLENGE FOR THE IVD MARKET
  • TABLE 5: GLOBAL IVD MARKET, BY PRODUCT & SERVICE, 2013-2020 (USD MILLION)
  • TABLE 6: GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL IVD INSTRUMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL IVD INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 12: GLOBAL IVD SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: GLOBAL IVD SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL IVD MARKET, BY TECHNOLOGY, 2013 - 2020 (USD MILLION)
  • TABLE 15: GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TEST, 2013-2020 (USD MILLION)
  • TABLE 17: GLOBAL BASIC METABOLIC PANELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL ELECTROLYTE PANELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: GLOBAL LIVER PANELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: GLOBAL LIPID PROFILES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL RENAL PROFILES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: GLOBAL THYROID FUNCTION PANELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: GLOBAL SPECIALTY CHEMICAL TESTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 27: GLOBAL ELISA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS (CLIA) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: GLOBAL RAPID TESTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: GLOBAL ELISPOT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 35: GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: GLOBAL COAGULATION & HEMOSTASIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 40: GLOBAL PCR MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 41: GLOBAL INAAT MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: GLOBAL MICROARRAYS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 43: GLOBAL HYBRIDIZATION MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 44: GLOBAL DNA SEQUENCING & NGS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 45: GLOBAL OTHER MDX TECHNOLOGIES MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: GLOBAL OTHER IVD TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 47: GLOBAL IVD MARKET SIZE, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 48: GLOBAL DIABETIC PATIENT POPULATION (2014)
  • TABLE 49: GLOBAL IVD MARKET SIZE FOR DIABETES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 50: GLOBAL IVD MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 51: GLOBAL IVD MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 52: GLOBAL IVD MARKET SIZE FOR CARDIOLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 53: GLOBAL IVD MARKET SIZE FOR NEPHROLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 54: GLOBAL IVD MARKET SIZE FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 55: GLOBAL IVD MARKET SIZE FOR DRUG TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 56: GLOBAL IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 57: GLOBAL IVD MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 58: GLOBAL IVD MARKET, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: GLOBAL IVD MARKET SIZE FOR LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 60: GLOBAL IVD MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: GLOBAL IVD MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 62: GLOBAL IVD MARKET SIZE FOR POC TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 63: GLOBAL IVD MARKET SIZE FOR PATIENT SELF-TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 64: GLOBAL IVD MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 65: GLOBAL IVD MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 66: GLOBAL IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 67: NORTH AMERICA: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 68: NORTH AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICES 2013-2020 (USD MILLION)
  • TABLE 69: NORTH AMERICA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 70: NORTH AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 71: NORTH AMERICA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 72: U.S.: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 73: U.S.: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 74: U.S.: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 75: U.S.: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 76: CANADA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 77: CANADA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 78: CANADA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 79: CANADA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 80: EUROPE: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 81: EUROPE: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 82: EUROPE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 83: EUROPE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 84: EUROPE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 85: GERMANY: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 86: GERMANY: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 87: GERMANY: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 88: GERMANY: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 89: FRANCE: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 90: FRANCE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 91: FRANCE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 92: FRANCE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 93: U.K.: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 94: U.K.: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 95: U.K.: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 96: U.K.: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 97: ITALY: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 98: ITALY: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 99: ITALY: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 100: ITALY: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 101: SPAIN: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 102: SPAIN: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 103: SPAIN: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 104: SPAIN: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 105: RUSSIA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 106: RUSSIA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 107: RUSSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 108: RUSSIA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 109: ROE: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 110: ROE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 111: ROE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 112: ROE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 113: APAC: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 114: APAC: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 115: APAC: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 116: APAC: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 117: APAC: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 118: JAPAN: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 119: JAPAN: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 120: JAPAN: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 121: JAPAN: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 122: CHINA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 123: CHINA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 124: CHINA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 125: CHINA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 126: INDIA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 127: INDIA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 128: INDIA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 129: INDIA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 130: ROAPAC: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 131: ROAPAC: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 132: ROAPAC: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 133: ROAPAC: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 134: ROW: IVD MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 135: ROW: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 136: ROW: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 137: ROW: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 138: ROW: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 139: LATIN AMERICA: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 140: LATIN AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 141: LATIN AMERICA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 142: LATIN AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 143: LATIN AMERICA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 144: BRAZIL: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 145: BRAZIL: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 146: BRAZIL: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 147: BRAZIL: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 148: MEXICO: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 149: MEXICO: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 150: MEXICO: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 151: MEXICO: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 152: ROLA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 153: ROLA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 154: ROLA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 155: ROLA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 156: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY PRODUCT & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 157: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 158: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 159: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 160: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 161: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
  • TABLE 162: MERGERS AND ACQUISITIONS, 2012-2015
  • TABLE 163: EXPANSIONS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL IN VITRO DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL IVD MARKET SIZE, BY PRODUCTS & SERVICES, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: GLOBAL IVD MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: GLOBAL IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: IVD MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 11: CHINA AND INDIA TO DRIVE THE GROWTH OF THE IVD MARKET IN ASIA-PACIFIC REGION
  • FIGURE 12: INCREASING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING GROWTH IN THE IVD MARKET
  • FIGURE 13: REAGENTS & KITS TO ACCOUNT FOR THE LARGEST SHARE OF THE IVD MARKET IN NORTH AMERICA
  • FIGURE 14: U.S. TO COMMAND MORE THAN ONE-THIRD OF THE GLOBAL IVD MARKET
  • FIGURE 15: NORTH AMERICA TO DOMINATE THE MOLECULAR DIAGNOSTICS & MICROBIOLOGY MARKETS
  • FIGURE 16: EMERGING MARKETS ARE ESTIMATED TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD
  • FIGURE 17: IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 18: IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 19: IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 20: IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY END USER
  • FIGURE 21: IVD MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 22: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 23: REGULATORY APPROVAL PROCESS IN CHINA
  • FIGURE 24: REGULATORY APPROVAL PROCESS IN INDIA
  • FIGURE 25: REAGENTS & KITS THE FASTEST GROWING SEGMENT OF THE IVD MARKET
  • FIGURE 26: MOLECULAR DIAGNOSTICS WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD OF 2015-2020
  • FIGURE 27: ONCOLOGY IS THE FASTEST-GROWING SEGMENT OF THE IVD MARKET
  • FIGURE 28: GLOBAL IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 29: NORTH AMERICA TO DOMINATE THE IVD MARKET
  • FIGURE 30: NORTH AMERICAN IVD MARKET OVERVIEW
  • FIGURE 31: EUROPEAN IVD MARKET OVERVIEW
  • FIGURE 32: PLAYERS MAJORLY ADOPTED THE STRATEGY OF NEW PRODUCT LAUNCHES FROM 2012 TO 2015
  • FIGURE 33: GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 34: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 35: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
  • FIGURE 36: COMPANY SNAPSHOT: ABBOTT LABORATORIES, INC.
  • FIGURE 37: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 38: COMPANY SNAPSHOT: JOHNSON AND JOHNSON
  • FIGURE 39: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE LTD.
  • FIGURE 40: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 41: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 42: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 43: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 44: COMPANY SNAPSHOT: SYSMEX CORPORATION
  • FIGURE 45: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
Back to Top